Patent 11938201

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-pro

PTAB activity (1)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

1 active
  • IPR2026-00069IPRfiled Oct 21, 2025vs. GE Healthcare Ltd. et al.Trial Instituted

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (3)

Group view →

Specific litigation cases in our database that name US patent 11938201. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

As a patent attorney, I can report the following known litigation involving U.S. Patent No. 11,938,201. The patent, titled "Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)," has been the subject of multiple proceedings before the Patent Trial and Appeal Board (PTAB).

Based on available information, here are the details of the known litigation:

Post-Grant Review (PGR) Proceedings

1. PGR2025-00012

  • Petitioner: ITM Isotope Technologies Munich SE
  • Patent Owner: The Johns Hopkins University
  • Jurisdiction: Patent Trial and Appeal Board (PTAB)
  • Case Number: PGR2025-00012
  • Filing Date: December 24, 2024
  • Outcome or Current Status: The case resulted in a settlement, with a termination date of October 16, 2025. An institution decision date was noted as July 16, 2025.

Inter Partes Review (IPR) Proceedings

1. IPR2025-00808

  • Petitioner: GE Healthcare Ltd.
  • Patent Owner: The Johns Hopkins University
  • Jurisdiction: Patent Trial and Appeal Board (PTAB)
  • Case Number: IPR2025-00808
  • Filing Date: March 27, 2025, or March 28, 2025
  • Outcome or Current Status: This proceeding was procedurally terminated. An institution decision date was noted as July 23, 2025.

2. IPR2026-00069

  • Petitioner: GE Healthcare Ltd.
  • Patent Owner: Johns Hopkins University
  • Jurisdiction: Patent Trial and Appeal Board (PTAB)
  • Case Number: IPR2026-00069
  • Filing Date: October 21, 2025
  • Outcome or Current Status: The current status is "Pending - Instituted." GE Healthcare has challenged claims 1-3 of the patent. The petitioner argues that these claims are obvious over prior art references US-633, Meletta, and Jansen.

At present, no litigation in U.S. District Courts or the U.S. Court of Appeals for the Federal Circuit involving US patent 11,938,201 has been identified. The known disputes are currently limited to the specialized proceedings before the PTAB.

Generated 5/13/2026, 12:18:16 AM